New Jersey Health Systems Adopted Medical Technologies
Providers in New Jersey integrated specialized surgical and therapeutic systems to expand their local clinical capabilities.
Updated on Oct. 7, 2026 in Healthcare
Live Poll
Do you believe new hospital technologies are making healthcare better for your household?
Throughout September 2026, various New Jersey health systems implemented new medical technologies across multiple specialties. The installations included advanced imaging platforms and novel nerve-stimulation therapies for patient care.
Why it matters
These infrastructure investments signal a shift in regional service competition, as providers upgrade equipment to support more complex, minimally invasive procedures. For operators, the expansion reflects a trend of local hospitals prioritizing capital-intensive technology to maintain market share.
Six New Jersey healthcare facilities integrated new systems in September 2026, ranging from photon therapy platforms to nerve-stimulation devices. The scope of these upgrades spanned facilities in Freehold, Summit, Atlantic City, Paramus, and Ridgewood.
The players
Atlantic Health CentraState Medical Center
A medical facility that recently integrated the TrueBeam photon therapy system for cancer treatment.
Overlook Medical Center
A healthcare provider that began utilizing the SetPoint System to treat rheumatoid arthritis.
AtlantiCare Regional Medical Center
A major regional healthcare system that employs the SetPoint System for patient care.
Englewood Hospital
A medical institution that performed a specialized transcatheter mitral valve replacement procedure.
The Valley Hospital
A healthcare organization that acquired the Elekta Esprit Gamma Knife system for precision neurosurgery.
The details
The technological expansion focuses on increasing precision and reducing invasiveness in standard care. This includes the TrueBeam system for oncology, the SetPoint System that stimulates the vagus nerve to manage inflammation, and the SAPIEN M3 procedure, which allows mitral valve replacement via leg vein catheterization. Additionally, providers have added focused shockwave therapy for pain management and Gamma Knife systems for neurological treatments.
Timeline
February 2026: First SetPoint device implanted at Overlook Medical Center.
September 14, 2026: Announcement of TrueBeam platform at Statesir Cancer Center.
September 28, 2026: Announcements for SetPoint System and Elekta Esprit system.
September 30, 2026: Announcement of focused shockwave therapy service.
October 6, 2026: Announcement of transcatheter mitral valve replacement.
Market Landscape
The adoption of the Elekta Esprit Gamma Knife system marks a local acceleration of the broader industry trend toward specialized, minimally invasive neurological intervention. This expansion follows the established pattern of major regional health systems investing in proprietary platforms to compete.
Operators should monitor whether these facility-specific technology upgrades shift patient referral patterns within their respective regions. Smaller practices should evaluate how these service additions influence local demand for diagnostic coordination and post-procedure outpatient care.
The takeaway
Healthcare providers are increasingly utilizing targeted technological acquisitions to differentiate their service offerings in a competitive market. Operators should track these equipment rollouts to determine if they necessitate changes in local referral or partnership strategy.
Further reading
For broader context on regional service shifts, visit the Healthcare section.
Source note: This article includes information reported by NJBIZ.
Live Poll
Do you believe new hospital technologies are making healthcare better for your household?
